InvestorsHub Logo
Followers 6
Posts 3891
Boards Moderated 0
Alias Born 01/14/2001

Re: None

Friday, 09/01/2006 3:49:56 AM

Friday, September 01, 2006 3:49:56 AM

Post# of 82595
DNAPrint Pharmaceuticals Completes The Development Of An Analytical Method That Will Be Used For The Development Of PT-401
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that its subsidiary, DNAPrint Pharmaceuticals, Inc., has completed the development of the so-called "Western blot" method, an analytical procedure that identifies a protein according to its interaction with a specific antibody, a significant step in the development of its PT-401-based proprietary drug to treat anemia.
(See Story from BioSpace.com) (07/31/2006)

Ann